BioCentury
ARTICLE | Clinical News

Arris regulatory update

July 8, 1996 7:00 AM UTC

ARRS received two U.S. patents. U.S. Patent No. 5,525,623 covers compositions and methods to treat immunomediated inflammatory disorders, and relates to ARRS's APC-336 tryptase inhibitor. U.S. Patent...